View PDF Version
 
DOI: 10.1039/A607794C (Paper) Reference Section for: Analyst, 1997, 122, 609-613

Determination of Aflatoxin B1–DNA Adduct in Rat Liver by Enzyme Immunoassay

(Note: The full text of this document is currently only available in the PDF Version )

T. Vidyasagar, N. Sujatha and R. B. Sashidhar

Abstract

A simple, rapid and highly sensitive indirect competitive enzyme-linked immunosorbent assay (ELISA) to determine aflatoxin B1 (AFB1)–DNA adducts is reported. Polyclonal antibodies specific to the aflatoxin B1–N7–guanine adduct were produced using a novel synthetic antigen, bovine serum albumin (BSA)–guanine– AFB1. The antibodies were characterized by the Ouchterlony double diffusion technique and by antibody capture assay. The working range of the indirect competitive assay developed was between 0.45 and 330 ng of the analyte [calf thymus (CT)–DNA–AFB1]. A 50% inhibition was attained at 15 ng of the analyte (CT–DNA–AFB1). The antibody capture assay indicated that the antibody produced cross-reacted 100, 92 and 110% with BSA–guanine–AFB1, CT-DNA–AFB1 and CT-DNA–formamidopyrimidine–AFB1, respectively. When free AFB1 and guanine were used as competing analytes, the antibodies showed ≤5% and zero cross-reactivity at the 50% inhibition level. Spiking studies indicated a recovery in the range 96–97 and 74–78% when standard CT-DNA–AFB1 was added to 10 mM phosphate buffer (pH 7.2) and control rat liver tissue, respectively. Rats exposed to a single oral dose of 1 mg kg-1 body mass of pure AFB1 were used to validate the method. The AFB1–DNA adduct formed in the liver tissue after 48 h of exposure was determined using the ELISA method developed. The liver AFB1–DNA adduct ranged between 6.06 and 7.94 µg mg-1 DNA. The proposed method may find application in the biological monitoring of aflatoxin B1 in molecular epidemiological studies to assess the dietary exposure of aflatoxins.

References

  1. W. F. Busby, Jr. and G. N. Wogan, in Chemical Carcinogens, ed. Searle, C., American Chemical Society, Washington, DC, 1984, pp. 945–1136 Search PubMed .
  2. International Agency for Research on Cancer, Monographs on the Evaluation of Carcinogenic Risk to Humans: Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins, IARC, Lyon, 1993, vol. 56, pp. 245–395 Search PubMed .
  3. J. D. Groopman, L. G. Cain and T. W. Kensler, CRC Crit. Rev. Toxicol., 1988, 19, 113 Search PubMed .
  4. H. Autrup, T. Seremet, J. Wakhisi and A. Wasunna, Cancer Res., 1987, 47, 3430 CAS .
  5. J. D. Groopman, A. J. Hall, H. Whittle, G. J. Hudson, G. N. Wogan, R. Montesano and C. P. Wild, Cancer Epidemiol. Biomarkers Prev., 1992, 1, 221 Search PubMed .
  6. F. S. Yeh, M. C. Yu, C. C. Mo, S. Luo, M. J. Tong and B. E. Henderson, Cancer Res., 1989, 49, 2506 CAS .
  7. D. M. Parkin, J. Stjernsward and C. S. Muir, Bull. W.H.O., 1984, 62, 163 Search PubMed .
  8. D. L. Eaton and E. P. Gallagher, Annu. Rev. Pharmacol. Toxicol., 1994, 34, 135 CrossRef CAS .
  9. C. P. Wild, G. J. Hudson, G. Sabbioni, B. Chapot, A. J. Hall, G. N. Wogan, H. Whittle, R. Montesano and J. D. Groopman, Cancer Epidemiol. Biomarkers Prev., 1992, 1, 229 Search PubMed .
  10. F. P. Guengerich, W. W. Johnson, R. F. Ueng, H. Yamazaki and T. Shimada, Environ. Health Perspect., 1996, 104, 557 CAS .
  11. R. S. Iyer, B. F. Coles, K. D. Raney, R. Thier, F. P. Guengerich and T. M. Harris, J. Am. Chem. Soc., 1994, 116, 1603 CrossRef CAS .
  12. C. N. Martin and R. C. Garner, Nature (London), 1977, 267, 863 CAS .
  13. J. D. Groopman, P. R. Donahue, J. Zhu, J. Chem and G. N. Wogan, Proc. Natl. Acad. Sci. USA, 1985, 83, 6492 .
  14. J. D. Groopman, in Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention, ed. Bartsch, H., Hemminki, K., and O'Neill, I. K., IARC Scientific publications, vol. 89, IARC, Lyon, 1988, pp. 52–62 Search PubMed .
  15. L. L. Hshieh, S. W. Hsu, D. S. Chen and R. M. Santella, Cancer Res., 1988, 48, 6328 .
  16. J. D. Groopman, J. A. Hassler, L. J. Trudel, A. Pikul, P. R. Donahue and G. N. Wogan, Cancer Res., 1992, 52, 267 CAS .
  17. C. J. Harrison and R. C. Garner, Carcinogenesis, 1991, 12, 741 .
  18. C. P. Wild, R. Montesano, J. Van Bentham, E. Scherer and L. Den Engelse, J. Cancer Res. Clin. Oncol., 1990, 116, 134 CAS .
  19. Handling Chemical Carcinogens in the Laboratory: Problems of Safety, ed. Montesano, R., Bartsch, H., Boyland, E., Della Porta, G., Fishbein, L., Griesemer, R. A., Swan, A. B., and Tomatis, L., IARC, Lyon, 1979, vol. 33 Search PubMed .
  20. NIH, National Institutes of Health Guidelines for Laboratory Use of Chemical Carcinogens, US Department of Health and Human Service, Washington, DC, 1981 Search PubMed .
  21. M. H. W. Van Regen Mortal, J. P. Briand, S. Muller and S. Plaue, in Laboratory Techniques in Biochemistry and Molecular Biology, ed Burdon, R. H., and Van Knippenberg, P. H., Elsevier, Amsterdam, p. 95 1988, vol. 19 Search PubMed .
  22. R. S. Iyer and T. M. Harris, Chem. Res. Toxicol., 1993, 6, 313 CrossRef CAS .
  23. R. B. Sashidhar, A. K. Capoor and D. Ramana, J. Immunol. Methods., 1994, 167, 121 CrossRef CAS .
  24. D. Ramana, A. K. Capoor, R. B. Sashidhar and R. V. Bhat, Fresenius' J. Anal. Chem., 1995, 353, 43 CrossRef .
  25. O. Ouchterlony, Ark. Kemi Mineral. Geol., 1949, 26, 1 Search PubMed .
  26. J. D. Groopman, W. F. Busby and G. N. Wogan, Cancer Res., 1980, 40, 4343 CAS .
  27. K. W. Giles and A. Myers, Nature (London), 1965, 206, 93 CAS .
  28. J. D. Groopman, R. G. Croy and G. N. Wogan, Proc. Natl. Acad. Sci. USA, 1981, 78, 5445 CAS .
Click here to see how this site uses Cookies. View our privacy policy here.